Corpus Intelligence IC Memo — UNIVERSITY OF NORTH CAROLINA HOSP. 2026-04-26 06:40 UTC
IC Memo — UNIVERSITY OF NORTH CAROLINA HOSP.
Investment Committee Memorandum | NC | 799 beds | Grade B | EBITDA uplift $212.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UNIVERSITY OF NORTH CAROLINA HOSP.

CCN 340061 | ORANGE, NC | 799 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

UNIVERSITY OF NORTH CAROLINA HOSP. is a 799-bed large academic medical center in ORANGE, NC with $2.88B in net patient revenue and a 13.3% operating margin. The hospital serves a payer mix of 16.7% Medicare, 9.1% Medicaid, and 74.1% commercial.

Thesis: Platform Growth. Our ML models identify $212.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.3% to 20.7% (+736bps).

Net Revenue HCRIS$2.88B
Current EBITDA COMPUTED$383.0M
Operating Margin COMPUTED13.3%
Occupancy HCRIS91.2%
Revenue / Bed COMPUTED$3.6M
Net-to-Gross HCRIS41.9%
Distress Probability ML39.6%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
15
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 13.3% places it above the state median. Among 15 size-comparable peers (400-1598 beds), the median margin is -3.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (400-1598), prioritizing same-state peers. 15 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UNIVERSITY OF NORTH CAROLINA H (Target)NC799$2.88B13.3%
DUKE UNIVERSITY HOSPITALNC1048$3.16B-4.5%
CAROLINAS MEDICAL CENTERNC1142$3.03B-5.5%
NORTH CAROLINA BAPTIST HOSPITANC800$2.19B-4.7%
REX HOSPITALNC489$1.51B-0.8%
PITT COUNTY MEMORIAL HOSPITALNC1013$1.38B-3.0%
FORSYTH MEMORIAL HOSPITAL INCNC906$1.36B-7.1%
PRESBYTERIAN HOSPITALNC561$1.33B1.0%
MISSION HOSPITAL INCNC733$1.30B7.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $212.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$60.5M+210bp18mo
Cost to Collect4.5%2.5%$57.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$57.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$35.1M+122bp9mo
Clean Claim Rate88.0%96.0%$1.8M+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$60.5M
Cost to Collect
$57.6M
Denial Rate Reduction
$57.1M
A/R Days Reduction
$35.1M
Clean Claim Rate
$1.8M
Total EBITDA Uplift$212.1M
Current EBITDA$383.0M
+ RCM Uplift+$212.1M
Pro Forma EBITDA$595.1M
Current Margin13.3%
Pro Forma Margin20.7%
WC Released (1x)$110.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$589.3M$4.65B7.89x51.1%
Base (11x exit)10.0x11.0x$589.3M$5.30B9.00x55.2%
Bull Case9.0x11.0x$530.3M$6.20B11.68x63.5%
Bull (12x exit)9.0x12.0x$530.3M$6.91B13.04x67.1%
Bear Case11.0x10.0x$648.2M$3.40B5.24x39.3%
Bear (11x exit)11.0x11.0x$648.2M$3.95B6.09x43.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 15 hospitals with 400-1598 beds
  • Same-state prioritization (n=16)
  • Comp margins: P25=-5.1% / P50=-3.0% / P75=4.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.